Infection treatment. microenvironment-to-microorganism-type-specific, low intensity direct current. Effective for bacterial, viral and antibiotic resistant superbug infections.
Bioelectric healing. Realtime, self adaptive supplementation or replacement of the bioelectric controller of wound healing—the wound-generated electric field; boosts the natural 'current of injury'.
Accelerated healing. Targeted bio-signaling stimulation of intracellular 'second messenger' molecule pathways: cyclic-A-M-P and cyclic-G-M-P that relay and amplify the messages for metabolic activity and healing.
Better healing, less scar tissue. Stimulates the self-modification of fibroblast cells in the wound to have tissue regeneration abilities resembling stem cell potentials.
Reduces pain. Decreases the 'action potential' electrical voltage of pain nerve cell 'voltage-gated' ion channels, reducing or stopping the transmission of pain signals.
SIS electrodes do not contact wound. No discomfort or disturbance of new (granulation) tissue growth.
No drug side effects or risks. Quick and easy to apply. For home and in clinic use.
Artificial Intelligence (AI) machine learning. Repeated electrical stimulation optimization for each individual wound. Device learns how to heal each specific wound and continuously improves its function.
International Patent Application Pending device & technology.